with the NHS
Designed Specifically for the NHS
Skin Analytics’ clincally approved DERM AI platform enables the NHS to efficiently manage demand by directing people to the most appropriate care pathway. It transforms how doctors manage resources, saving money in workforce efficiencies by allowing Doctors, Nurses and HCA’s to assess patients to the same level as a dermatologist.Skin
Skin Analytics platform is designed to
- Reduce costs and improve accessibility
- Improve health outcomes
- Better clinical governance
- Improve patient experience
- Improve capacity and efficiencies
Reducing costs and adding valuable benefits
Our unique AI technology provides dermatology capacity by identifying 11 different lesion types. These range from malignant and pre-malignant lesions that can be treated if assessed early enough, through to benign lesions where patients can be discharged or referred for further monitoring.
DERM AI can sit in existing medical photography hubs for teledermatology, and be able to discharge 30-40% of cases initially. Additional capacity gains can be made should the dermatologists be happy to list the malignant lesions directly for biopsy, saving another dermatology appointment per listed patient.